Advertisement

Thrombocytopenia and outcome in critically ill patients with bloodstream infection

Published:October 16, 2009DOI:https://doi.org/10.1016/j.hrtlng.2009.07.005

      Objective

      Thrombocytopenia is common in intensive care units (ICUs), and is associated with a poor prognosis. An acute decrease in total platelet count is frequently observed in severe sepsis, followed by a relative increase indicating organ-failure recovery. However, few data are available describing this effect and its relationship with outcomes in specific subgroups of ICU patients.

      Methods

      A retrospective, observational cohort study was conducted to investigate the incidence and prognosis of thrombocytopenia in a cohort of critically ill patients (n=155) with a microbiologically documented nosocomial bloodstream infection.

      Results

      Thrombocytopenia occurred more frequently in nonsurvivors. The ICU mortality rates increased according to severity of thrombocytopenia. Thrombocytopenia was independently associated with worse outcomes in ICU patients with nosocomial bloodstream infection.

      Conclusion

      Determining trends in platelet counts is of additional prognostic value, compared with single measurements.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart & Lung: The Journal of Cardiopulmonary and Acute Care
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Stephan F.
        • Hollande J.
        • Richard O.
        • Cheffi A.
        • Maier-Redelsperger M.
        • Flahault A.
        Thrombocytopenia in a surgical ICU.
        Chest. 1999; 115: 1363-1370
        • Strauss R.
        • Wehler M.
        • Mehler K.
        • Kreutzer D.
        • Koebnick C.
        • Hahn E.G.
        Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome.
        Crit Care Med. 2002; 30: 1765-1771
        • Vanderschueren S.
        • De Weerdt A.
        • Malbrain M.
        • Vankersschaever D.
        • Frans E.
        • Wilmer A.
        • et al.
        Thrombocytopenia and prognosis in intensive care.
        Crit Care Med. 2000; 28: 1871-1876
        • Blot S.I.
        • Depuydt P.
        • Annemans L.
        • Benoit D.
        • Hoste E.
        • De Waele J.J.
        • et al.
        Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections.
        Clin Infect Dis. 2005; 41: 1591-1598
        • Blot S.I.
        • Vandewoude K.H.
        • Hoste E.A.
        • Colardyn F.A.
        Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
        Arch Intern Med. 2002; 162: 2229-2235
        • Vincent J.L.
        • de Mendonca A.
        • Cantraine F.
        • Moreno R.
        • Takala J.
        • Suter P.M.
        • et al.
        Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working Group on “Sepsis-Related Problems” of the European Society of Intensive Care Medicine.
        Crit Care Med. 1998; 26: 1793-1800
        • Hoste E.A.
        • Vandijck D.M.
        • Van Holder R.C.
        • De Waele J.J.
        • Lameire N.H.
        • Claus S.
        • et al.
        Health implications of antimicrobial-resistance in bloodstream infection patients with acute kidney injury.
        Infect Control Hosp Epidemiol. 2007; 28: 1107-1110
        • Ibrahim E.H.
        • Sherman G.
        • Ward S.
        • Fraser V.J.
        • Kollef M.H.
        The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting.
        Chest. 2000; 118: 146-155
        • Colardyn F.
        Appropriate and timely empirical antimicrobial treatment of ICU infections—a role for carbapenems.
        Acta Clin Belg. 2005; 60: 51-62
        • Blot S.
        • Vandewoude K.
        • De Bacquer D.
        • Colardyn F.
        Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization.
        Clin Infect Dis. 2002; 34: 1600-1606
        • Crowther M.A.
        • Cook D.J.
        • Meade M.O.
        • Griffith L.E.
        • Guyatt G.H.
        • Arnold D.M.
        • et al.
        Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors.
        J Crit Care. 2005; 20: 348-353
        • Levy M.M.
        • Fink M.P.
        • Marshall J.C.
        • Abraham E.
        • Angus D.
        • Cook D.
        • et al.
        2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.
        Crit Care Med. 2003; 31: 1250-1256
        • Akca S.
        • Haji-Michael P.
        • de Mendonca A.
        • Suter P.
        • Levi M.
        • Vincent J.L.
        Time course of platelet counts in critically ill patients.
        Crit Care Med. 2002; 30: 753-756
        • George J.N.
        • Raskob G.E.
        • Shah S.R.
        • Rizvi M.A.
        • Hamilton S.A.
        • Osborne S.
        • et al.
        Drug-induced thrombocytopenia: a systematic review of published case reports.
        Ann Intern Med. 1998; 129: 886-890
        • Levi M.
        • Opal S.M.
        Coagulation abnormalities in critically ill patients.
        Crit Care. 2006; 10: 222
        • Niemi T.T.
        • Backman J.T.
        • Syrjala M.T.
        • Viinikka L.U.
        • Rosenberg P.H.
        Platelet dysfunction after intravenous ketorolac or propacetamol.
        Acta Anaesthesiol Scand. 2000; 44: 69-74
        • Levi M.
        Platelets in sepsis.
        Hematology. 2005; 10: 129-131
        • Russwurm S.
        • Vickers J.
        • Meier-Hellmann A.
        • Spangenberg P.
        • Bredle D.
        • Reinhart K.
        • et al.
        Platelet and leukocyte activation correlate with the severity of septic organ dysfunction.
        Shock. 2002; 17: 263-268
        • Vandijck D.M.
        • Blot S.I.
        • Decruyenaere J.M.
        The value of sepsis definitions in daily ICU-practice.
        Acta Clin Belg. 2006; 61: 219-225
        • Vandijck D.M.
        • Blot S.I.
        • De Waele J.J.
        • Hoste E.A.
        • Vandewoude K.H.
        • Decruyenaere J.M.
        Thrombocytopenia as a marker of poor outcome in ICU patients with severe bloodstream infection.
        Crit Care Med. 2007; 34: A137
        • Nijsten M.W.
        • ten Duis H.J.
        • Zijlstra J.G.
        • Porte R.J.
        • Zwaveling J.H.
        • Paling J.C.
        • et al.
        Blunted rise in platelet count in critically ill patients is associated with worse outcome.
        Crit Care Med. 2000; 28: 3843-3846
        • Arnold D.M.
        • Crowther M.A.
        • Cook R.J.
        • Sigouin C.
        • Heddle N.M.
        • Molnar L.
        • et al.
        Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
        Transfusion. 2006; 46: 1286-1291
        • Spapen H.D.
        • Hachimi-Idrissi S.
        • Corne L.
        • Huyghens L.P.
        Diagnostic markers of sepsis in the emergency department.
        Acta Clin Belg. 2006; 61: 138-142